CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: December-20-13
Credit Expiration Date: December-20-14


Contributing Author:
Nicola A. Hanania, MD, MS
Associate Professor of Medicine
Pulmonary and Critical Care Medicine
Director, Asthma Clinical Research Center
Baylor College of Medicine
Houston, TX

Series Chair:
James F. Donohue, MD
Professor of Medicine
Division of Pulmonary and Critical Care Medicine
University of North Carolina at Chapel Hill
Chapel Hill, NC

CCME Reviewer:
Victor B. Hatcher, PhD
Professor of Medicine and Biochemistry
Associate Dean, CME and Research
Albert Einstein College of Medicine
Director of CME, Director of the Office of Research and Sponsored Programs
Montefiore Medical Center
Bronx, NY

Credit Hours

Physicians: 0.75 AMA PRA Category 1 CreditTM



Program Description

An interactive CME-certified interactive newsletter series on the treatment of chronic obstructive pulmonary disease (COPD).

COPD is a slowly progressive respiratory disease characterized by airflow limitation that is not fully reversible. Manifestations of COPD include dyspnea, poor exercise tolerance, chronic cough with or without sputum production, wheezing, and respiratory failure or right heart failure. In the United States, COPD affects more than 5% of the adult population and is the third leading cause of death. Advances in medical therapies and better disease management approaches have increased the recognition that COPD is preventable and treatable. Yet, COPD remains both underdiagnosed and undertreated in primary care settings.

To reduce the health burden caused by COPD, pulmonologists and primary care clinicians need to enhance their ability to diagnose and assess COPD, to implement pulmonary rehabilitation interventions, and to effectively use long-term maintenance therapy. The goal of this CME activity is to expand the ability of primary care clinicians to provide optimal management of COPD, ultimately improving outcomes for the many patients who suffer from COPD.

Program Developer/Facilitator

This activity is jointly provided by Albert Einstein College of Medicine and Montefiore Medical Center, and MCM Education.

Target Audience

This activity is intended for primary care and internal medicine physicians, pulmonologists, and other clinicians interested and involved in the treatment of patients with COPD.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Outline current guidelines for the use of long-acting inhaled β2-agonists and combination therapy of stable COPD.
  2. Describe the side effects of long-acting inhaled β2-agonists and anticholinergic medications for COPD.
  3. Develop evidence-based treatment recommendations for the use of long-acting bronchodilators in the treatment of stable COPD.
  4. Discuss efficacy and safety data available on emerging investigational agents for stable COPD.


The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical, product, or device company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present. Albert Einstein College of Medicine and MCM Education staff have no conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product not yet approved for use in the United States.

Dr. Hanania Disclosures:
Grant support from GSK, Boehringer Ingelheim, Pfizer, Sunovion
Consultant to GSK, Boehringer Ingelheim, Pfizer
Speakers bureau for GSK, Merck

Dr. Donohue Disclosures:
Consultant to Almiral, Boehringer Ingelheim, GSK, Forest, Merck, Pfizer, Sunovion, Mylan, Gilead.
DSMB for Novartis, PneumRx, Otsuka

The staff of CCME of Albert Einstein College of Medicine have no disclosures to report with any commercial interests other than the following:
Steven Jay Feld, or a member of his household own securities in: Bioheart, Inc.; Chelsea Therapeutics, Inc.; Depomed; and Pharmacopeia, Inc.
Dr. Hatcher has no disclosures.

Kathleen Hines (MCM Education Editorial Director) has no disclosures.

Credit Statements

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship of Albert Einstein College of Medicine, Montefiore Medical Center and MCM Education. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Albert Einstein College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit is awarded to participants who score 75% or better on the post-test.

This activity will take approximately 45 minutes to complete.

Commercial Support Statements

Supported by an independent educational grant from Forest Laboratories, Inc.

Supported by an independent educational grant from Novartis.


There are no fees for participating in or receiving credit for this online educational activity. This activity is designed to be completed within the time designated on this page; physicians should claim only those credits that reflect the time actually spent in the activity.

  1. Review the intended audience, learning objectives, and author disclosures.
  2. Study the educational content online. Be sure to review both written and audio/slide content.
  3. Once completed, continue to post-test. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. In addition, you must also complete the Activity Evaluation.
  4. Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers

Certificate Fee



Presented by Albert Einstein College of Medicine & Montefiore Medical Center, Center for Continuing Medical Education, and MCM Education.

The opinions expressed in these educational activities are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Albert Einstein College of Medicine & Montefiore Medical Center, Center for Continuing Medical Education, Forest Laboratories, or Novartis. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu